Johnson & Johnson: valuation
What the market value assumes, and what the company's own statements and its peers' prices would put it at. Every assumption is yours to change.
Cash-flow value and what the price assumes
Average of FY2024–FY2025 (cash from operations less capital spending), from the statements below.
No three-year revenue growth on file: 5% to start with.
US Treasury 10-year yield on Nov 20, 2026: 4.92% (US Treasury).
Your assumption: the extra yearly return you want for holding shares rather than Treasuries. 5% is a round starting figure, not data.
Your assumption: long-run growth, usually near inflation. It must stay below the discount rate.
Debt or cash not on file: 0 to start with.
What today's price assumes
A market value of $652.5 B means free cash flow growing 14.3% a year for 10 years, then 2.5% for ever, at a 9.92% discount rate.
Against the market value, for other rates
Cash-flow value of the shares as a percentage above or below today's market value; your inputs in the middle.
| Discount rate ↓ / growth → | 0% | 2.5% | 5% | 7.5% | 10% |
|---|---|---|---|---|---|
| 7.92% | -53% | -43% | -30% | -15% | +3% |
| 8.92% | -60% | -52% | -42% | -29% | -15% |
| 9.92% | -65% | -58% | -50% | -40% | -27% |
| 10.92% | -69% | -63% | -56% | -47% | -37% |
| 11.92% | -72% | -67% | -61% | -54% | -45% |
On one scale
Bars: from the 25th to the 75th percentile multiple of the peers, the line at the median; dot: the cash-flow value with your inputs.
Your own DCF model
A full discounted-cash-flow model of Johnson & Johnson, started from its filings: revenue growth and margins year by year, bear, base and bull cases, the WACC and its parts, sensitivity tables and a value per share against the dated market price. Save it, share it with your team or by a read-only link.
Open the DCF modelAgainst its own history
Johnson & Johnson's multiples at each month end with a market cap on file, Jan 2020 to Oct 2026, each against its own median.
P/E
31.0×Now above its median of 24.3×, in the top quarter of its range; range 16.8× to 31.1× over 30 months.
Price to sales
6.7×Now above its median of 5.2×, in the top quarter of its range; range 4.0× to 6.7× over 30 months.
Price to book
8.0×Now above its median of 6.4×, in the top quarter of its range; range 5.0× to 8.0× over 30 months.
As of Oct 29, 2026
The statements it starts from
USD millions at each year's exchange rate; free cash flow = cash from operations less capital spending.
| Fiscal year | Revenue | Net income | Cash from operations | Capital spending | Free cash flow | Net debt | Source |
|---|---|---|---|---|---|---|---|
| FY2026 | — | — | — | — | — | — | Wikidata |
| FY2025to Dec 28, 2025 | $94.2 B | $26.8 B | $24.5 B | $4.8 B | $19.7 B | $21.7 B | SEC annual report (10-K, 20-F) |
| FY2024to Dec 29, 2024 | $88.8 B | $14.1 B | $24.3 B | $4.4 B | $19.8 B | $8.3 B | SEC annual report (10-K, 20-F) |
| FY2023to Dec 31, 2023 | $85.2 B | $35.2 B | $22.8 B | $4.5 B | $18.2 B | $5.5 B | SEC annual report (10-K, 20-F) |
| FY2022to Jan 1, 2023 | $80.0 B | $17.9 B | $21.2 B | $4.0 B | $17.2 B | $15.5 B | SEC annual report (10-K, 20-F) |
| FY2021to Jan 2, 2022 | $78.7 B | $20.9 B | $23.4 B | $3.7 B | $19.8 B | $17.6 B | SEC annual report (10-K, 20-F) |